RT Journal Article
SR Electronic
T1 Extended-spectrum beta-lactamase-producing <em>Escherichia coli</em> and <em>Klebsiella pneumoniae</em> from human carriage, the human-polluted environment, and food: molecular epidemiology of two prospective cohorts in five European metropolitan areas
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.11.21.24316745
DO 10.1101/2024.11.21.24316745
A1 Verschuuren, TD
A1 Guther, J
A1 Riccio, ME
A1 Martak, D
A1 Salamanca, E
A1 Göpel, S
A1 Conzelmann, N
A1 Scharringa, J
A1 Musicha, P
A1 Autenrieth, IB
A1 Cooper, BS
A1 Hocquet, D
A1 Tacconelli, E
A1 Rodríguez-Baño, J
A1 Harbarth, S
A1 Fluit, AC
A1 Peter, S
A1 Kluytmans, JAJW
YR 2024
UL http://medrxiv.org/content/early/2024/11/23/2024.11.21.24316745.abstract
AB Objectives For 475 ESBL-producing Escherichia coli (ESBL-Ec), and 171 ESBL-producing Klebsiella pneumoniae (ESBL-Kp) collected from human carriers, the human-polluted (hp)-environment, and food: (i) to compare the antimicrobial resistance gene (ARG) content, and (ii) to assess clonal relationships between human and non-human isolates.Methods Two prospective multicentre cohorts were assessed: colonised hospitalised index-subjects and household contacts, and long-term care facility (LTCF) residents. Additionally, linked hp-environment and food samples were collected. Presence of ARGs were assessed using pairwise comparisons and proportional similarity index (PSI). Clonal relationships were assessed using cgMLST distance visualisations and maximum likelihood phylogeny.Results ESBL-Ec and ESBL-Kp co-occurred in 14/65 households, 3/6 LTCFs, and in 33/202 of ESBL-positive participants. Thirty-nine percent of detected ARG types were found in both species (36/93). Frequencies of beta-lactamase, ESBL, aminoglycoside, and sulfonamide ARG types from human ESBL-Ec and ESBL-Kp overlapped considerably: PSIs 0.59-0.75, and were equal or higher compared to the overlap between ESBL-Ec from humans and food isolates: PSIs 0.33-0.72. Isolates from humans and the hp-environment were frequently clonally related, indicating human contamination of the environment. Links with food isolates were observed less frequently. For ESBL-Ec both interregional and regional clonal dissemination were observed, while for ESBL-Kp clonal dissemination was mainly regional.Conclusions ESBL-Ec and ESBL-Kp from human carriage showed considerable overlap in ARG content. Furthermore, clonal links were observed frequently between humans and hp-environment, and with lower frequency between humans and food. These findings are consistent with human-to-human transmission as an important driver of ARG spread in humans.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe MODERN studies (Understanding and modelling reservoirs, vehicles and transmission of ESBL producing Enterobacteriaceae in the community and long term care facilities) were part of a Joint Programming Initiative on Antimicrobial Resistance collaborative research project, under the 2016 Joint Call framework (Transnational Research Projects on the Transmission Dynamics of Antibacterial Resistance). It received funding from the following national research agencies: Instituto de Salud Carlos III (grant no. AC16/00076), Netherlands Organization for Health Research and Development (grant no. 681055, 547001004), Swiss National Science Foundation (grant no. 40AR40.173608), German Federal Ministry of Education and Research (grant no. 01KI1701), the French Agence Nationale de la Recherche (grant no. ANR.16.JPEC.0007.03), and UK Medical Research Council (grant no. MR/R004536/1). Elena Salamanca, and Jesus Rodriguez-Bano received support for research from by the Plan Nacional de I+D+i 2013 2016 and Instituto de Salud Carlos III, Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Ciencia, Innovacion y Universidades, Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0001), co-financed by the European Development Regional Fund A way to achieve Europe, Operative Program Intelligence Growth 2014 2020.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of University Medical Center Utrecht waived ethical approval for this work IRB of University Hospital Tubingen gave ethical approval for this work IRB of University of Geneva Hospitals and Faculty of Medicine gave ethical approval for this work IRB of University Hospital Virgen Macarena gave ethical approval for this work IRB of University Hospital Besancon gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesRaw reads are available on the European Nucleotide Archive (ENA), under the accession number PRJEB50545. Metadata with accession numbers are available in the supplementary material. Online access interactive maximum-likelihood trees: ESBL-Ec: https://microreact.org/project/wSXSAfjgAH1Xr9af46Hbcb-modern-project-esbl-e-coli-n475, ESBL-Kp: https://microreact.org/project/vRJHCdos8zWcv4yHMTKjak-modern-project-esbl-k-pneumoniae. https://www.ebi.ac.uk/ena/browser/view/PRJEB50545 https://microreact.org/project/wSXSAfjgAH1Xr9af46Hbcb-modern-project-esbl-e-coli-n475 https://microreact.org/project/vRJHCdos8zWcv4yHMTKjak-modern-project-esbl-k-pneumoniae